Isorhythmic A-V dissociation: Difference between revisions
No edit summary |
No edit summary |
||
Line 42: | Line 42: | ||
{|style="width:80%; height:100px" border="1" | {|style="width:80%; height:100px" border="1" | ||
|style="height:100px"; style="width:25%" border="1" bgcolor="LightSteelBlue" | '''Cardiovascular''' | |style="height:100px"; style="width:25%" border="1" bgcolor="LightSteelBlue" | '''Cardiovascular''' | ||
|style="height:100px"; style="width:75%" border="1" bgcolor="Beige" | [[Acute coronary syndrome]], [[acute rheumatic fever]], [[amyloidosis]], [[Andersen cardiodysrhythmic periodic paralysis]], [[Brugada syndrome]], [[cardiac tumor#heart in lymphomas|cardiac lymphoma]], [[cardiac transplantation]], [[Carotid sinus hypersensitivity|cardioinhibitory syncope]], [[complete heart block]], [[congenital heart disease]], [[congestive heart failure]], [[reperfusion injury|coronary reperfusion therapy]], [[dilated cardiomyopathy]], [[hypertensive heart disease]], [[hypertrophic cardiomyopathy]], [[ischemic heart disease]], [[Jervell and Lange-Nielsen syndrome]], [[Lev's disease]], [[long QT syndrome]], [[myocardial bridging]], [[myocardial contusion]], [[myocardial infarction]], [[myocardial rupture]], [[myocarditis]], [[NSTEMI]], [[pericarditis]], [[Romano-Ward syndrome]], [[sick sinus syndrome]], [[sinoatrial block]], [[sinus arrest]], [[sinus bradycardia]], [[sinus node fibrosis]], [[STEMI]], [[tachycardia-bradycardia syndrome]], [[Timothy syndrome]], [[valvular heart disease]] | |style="height:100px"; style="width:75%" border="1" bgcolor="Beige" | [[Acute coronary syndrome]], [[acute rheumatic fever]], [[amyloidosis]], [[Andersen cardiodysrhythmic periodic paralysis]], [[Brugada syndrome]], [[cardiac tumor#heart in lymphomas|cardiac lymphoma]], [[cardiac transplantation]], [[Carotid sinus hypersensitivity|cardioinhibitory syncope]], [[complete heart block]], [[congenital heart disease]], [[congestive heart failure]], [[reperfusion injury|coronary reperfusion therapy]], [[dilated cardiomyopathy]], [[hypertensive heart disease]], [[hypertrophic cardiomyopathy]], [[ischemic heart disease]], [[Jervell and Lange-Nielsen syndrome]], [[Lev's disease]], [[long QT syndrome]], [[myocardial bridging]], [[myocardial contusion]], [[myocardial infarction]], [[myocardial rupture]], [[myocarditis]], [[NSTEMI]], [[pericarditis]], [[Romano-Ward syndrome]], [[sick sinus syndrome]], [[sinoatrial block]], [[sinus arrest]], [[sinus bradycardia]], [[sinus node disease|sinus node fibrosis]], [[STEMI]], [[tachycardia-bradycardia syndrome]], [[Timothy syndrome]], [[valvular heart disease]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Chemical/Poisoning''' | | '''Chemical/Poisoning''' | ||
|bgcolor="Beige"| [[Berberine]], [[carbamate poisoning]], [[grayanotoxin]], [[organophosphate|organophosphate poisoning]], [[parathion poisoning]], [[poisonous spider bites]], [[pyrethroid poisoning]], [[scorpion toxin]] | |bgcolor="Beige"| [[Berberine]], [[carbamate|carbamate poisoning]], [[grayanotoxin]], [[organophosphate|organophosphate poisoning]], [[parathion poisoning]], [[spider bite#spider venom|poisonous spider bites]], [[pyrethroid|pyrethroid poisoning]], [[Arizona bark scorpion|scorpion toxin]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 78: | Line 78: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Genetic''' | | '''Genetic''' | ||
|bgcolor="Beige"| [[Brugada syndrome]], [[Emery-Dreifuss muscular dystrophy]], [[Jervell and Lange-Nielsen syndrome]], [[Kearns-Sayre syndrome]], [[limb-girdle muscular dystrophy type | |bgcolor="Beige"| [[Brugada syndrome]], [[Emery-Dreifuss muscular dystrophy]], [[Jervell and Lange-Nielsen syndrome]], [[Kearns-Sayre syndrome]], [[Limb-girdle muscular dystrophy|limb-girdle muscular dystrophy type 1B (LGMD1B)]], [[long QT syndrome]], [[muscular dystrophy]], [[myotonic dystrophy]], [[Romano-Ward syndrome]], [[Timothy syndrome]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 86: | Line 86: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Iatrogenic''' | | '''Iatrogenic''' | ||
|bgcolor="Beige"| [[Cardiac catheterization]], [[cardiac resynchronization therapy]], [[cardiac transplantation]], [[coronary artery bypass grafting]], [[Fontan procedure]], [[heart surgery]], [[ | |bgcolor="Beige"| [[Cardiac catheterization]], [[cardiac resynchronization therapy]], [[cardiac transplantation]], [[coronary artery bypass grafting]], [[Fontan procedure]], [[heart surgery]], [[lung transplantation|post lung transplantation]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 98: | Line 98: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Neurologic''' | | '''Neurologic''' | ||
|bgcolor="Beige"| [[Severe brain injury]] | |bgcolor="Beige"| [[brain damage|Severe brain injury]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 122: | Line 122: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Psychiatric''' | | '''Psychiatric''' | ||
|bgcolor="Beige"| [[Severe anorexia nervosa]], [[Takotsubo cardiomyopathy]] | |bgcolor="Beige"| [[anorexia nervosa|Severe anorexia nervosa]], [[Takotsubo cardiomyopathy]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 173: | Line 173: | ||
*[[Bupivacaine]] | *[[Bupivacaine]] | ||
*[[Calcium channel blockers]] | *[[Calcium channel blockers]] | ||
*[[Carbamate poisoning]] | *[[carbamate|Carbamate poisoning]] | ||
*[[Carbamazepine]] | *[[Carbamazepine]] | ||
*[[Cardiac catheterization]] | *[[Cardiac catheterization]] | ||
Line 220: | Line 220: | ||
*[[Idarubicin]] | *[[Idarubicin]] | ||
*[[Idiopathic]] | *[[Idiopathic]] | ||
*[[Ischemic heart disease]] | *[[Ischemic heart disease]] | ||
*[[Isoprenaline]] | *[[Isoprenaline]] | ||
Line 226: | Line 225: | ||
*[[Kearns-Sayre syndrome]] | *[[Kearns-Sayre syndrome]] | ||
*[[Lev's disease]] | *[[Lev's disease]] | ||
*[[Limb-girdle muscular dystrophy type | *[[Limb-girdle muscular dystrophy|Limb-girdle muscular dystrophy type 1B (LGMD1B)]] | ||
*[[Lithium]] | *[[Lithium]] | ||
*[[Long QT syndrome]] | *[[Long QT syndrome]] | ||
Line 246: | Line 245: | ||
*[[Neostigmine]] | *[[Neostigmine]] | ||
*[[Nicorandil]] | *[[Nicorandil]] | ||
*[[NSTEMI]] | |||
{{col-break|width=33%}} | {{col-break|width=33%}} | ||
*[[organophosphate|Organophosphate poisoning]] | |||
*[[organophosphate| | |||
*[[Parathion poisoning]] | *[[Parathion poisoning]] | ||
*[[Pericarditis]] | *[[Pericarditis]] | ||
Line 254: | Line 253: | ||
*[[Phenytoin]] | *[[Phenytoin]] | ||
*[[Pheochromocytoma]] | *[[Pheochromocytoma]] | ||
*[[Poisonous spider bites]] | *[[spider bite#spider venom|Poisonous spider bites]] | ||
*[[Post lung transplantation]] | *[[lung transplantation|Post lung transplantation]] | ||
*[[Procainamide]] | *[[Procainamide]] | ||
*[[Hypothyroidism]] | *[[Hypothyroidism]] | ||
Line 261: | Line 260: | ||
*[[Propanolol]] | *[[Propanolol]] | ||
*[[Propofol]] | *[[Propofol]] | ||
*[[Pyrethroid poisoning]] | *[[pyrethroid|Pyrethroid poisoning]] | ||
*[[Pyridostigmine]] | *[[Pyridostigmine]] | ||
*[[Quinidine]] | *[[Quinidine]] | ||
Line 269: | Line 268: | ||
*[[Ropivacaine]] | *[[Ropivacaine]] | ||
*[[Scleroderma]] | *[[Scleroderma]] | ||
*[[Scorpion toxin]] | *[[Arizona bark scorpion|Scorpion toxin]] | ||
*[[Septic shock]] | *[[Septic shock]] | ||
*[[Severe anorexia nervosa]] | *[[anorexia nervosa|Severe anorexia nervosa]] | ||
*[[Severe brain injury]] | *[[brain damage|Severe brain injury]] | ||
*[[Sick sinus syndrome]] | *[[Sick sinus syndrome]] | ||
*[[Sinoatrial block]] | *[[Sinoatrial block]] | ||
*[[Sinus arrest]] | *[[Sinus arrest]] | ||
*[[Sinus bradycardia]] | *[[Sinus bradycardia]] | ||
*[[Sinus node fibrosis]] | *[[sinus node disease|Sinus node fibrosis]] | ||
*[[Sjogren's syndrome]] | *[[Sjogren's syndrome]] | ||
*[[STEMI]] | *[[STEMI]] |
Revision as of 21:30, 3 September 2013
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vendhan Ramanujam M.B.B.S [2]
Synonyms and keywords: Isorhythmic AV dissociation
Overview
Isorhythmic AV dissociation is a AV dissociation initiated by slowing of SA node due to sinus arrhythmia, sinus bradycardia, sinus arrest, or sinoatrial block. This allows an independent ventricular pacemaker response like either junctional rhythm (giving a normal or near normal QRS appearance and duration) or idioventricular rhythm (with a more bizarre, wide QRS) to take over the ventricles. In the presence of some degree of antegrade and retrograde atrioventricular block, there is a synchronization of independently beating sinus or atrial pacemaker with the junctional or ventricular pacemaker such that each discharges in the absolute refractory period of the other.
Causes
Life Threatening Causes
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.
- Acute coronary syndrome
- Diabetic ketoacidosis
- Myocardial rupture
- NSTEMI
- Organophosphate poisoning
- STEMI
Common Causes
- Acetylcholine
- Acute coronary syndrome
- Acute rheumatic fever
- Amiodarone
- Antiarrhythmic agents
- Beta-blockers
- Calcium channel blockers
- Cardiac catheterization
- Cardiomyopathy
- Congestive heart failure
- Digitalis toxicity
- Diltiazem
- Hypertensive heart disease
- Ischemic heart disease
- Myocarditis
- Sick sinus syndrome
- Sinus arrest
- Sinus bradycardia
- STEMI